18/08/2026 17:04

Pro Medicus (ASX: PME) $196.75

PME +11.88%:  delivered another very strong FY26 result, comfortably beating consensus at the profit line and reinforcing why the market continues to pay such a large premium for the business. We liked the earnings beat; strong contract wins and a large implementation pipeline that should support further growth into FY27.

Read more

25/06/2026 09:18

Pro Medicus Ltd (ASX: PME) $178.99

PME is very much on the tech side of the healthcare sector, and we covered the stock in detail earlier in the month, here, before going long below $157. PME has been sold off on the software “AI Disruption Trade” but with its EPS set to increase by almost 60% between FY25 and FY27, the share price is all about the price investors are prepared to pay for this growth as the company continues to win new contracts at an exciting rate. The stock isn’t overly cheap, and we would certainly reconsider our position back around ~$220, the company's average long-term valuation area.

Read more

02/06/2026 09:47

Pro Medicus (ASX: PME) $144.46

Pro Medicus (PME) was one of the market’s favourite stocks in 2025, and while its ~$15bn valuation against revenue of only around ~$260m triggered a valuation reset, the business itself has continued to execute exceptionally well. Importantly, the recent pullback has been driven far more by multiple compression than any deterioration in the company’s fundamentals. In our view, PME remains the highest-quality and arguably most defensively positioned software business on the ASX.

Read more

21/05/2026 09:11

Pro Medicus Ltd (ASX: PME) $128.70

Pro Medicus is a high-margin Australian healthcare technology company that provides imaging software and cloud-based radiology platforms to major hospitals globally, benefiting from the structural digitisation of medical imaging and AI-driven healthcare workflows  - a mouthful, but effectively it’s a software company, sitting in the healthcare sector.

Read more

13/04/2026 09:37

Shawn’s Trade Idea: Buy Pro Medicus Ltd (ASX:PME) at $107.40

This bid in PME is similar to WTC in logic but due to the stock’s volatility we have placed our bid significantly lower, effectively buying a second wave of weakness in the ASX software names if we see panic early this week.

Read more

08/12/2025 09:45

Chart of the Week – Pro Medicus Ltd (PME)

It’s not just tech stocks that have struggled this FY, the “Certainty Trade” as it was labelled into June has largely been hammered from CBA to JB Hi-Fi. Another example is Pro Medicus (PME) which soared higher into June, ignoring valuation concerns, only to tumble ~28% in FY26 even as it continues to win new contracts but an Est. 164x valuation for FY26 its valuation remains daunting with rates set to increase.

Read more

16/10/2025 09:33

Pro Medicus Ltd (PME) $292.40

PME bounced back +1.9% on Wednesday after correcting 16% over recent months. In very similar fashion to CBA this momentum play lost support and fell away as the “hot money” went for the exits.

Read more

16/09/2025 09:44

Pro Medicus (PME) $294.14

Despite its name this medical imaging software and IT solutions business is far more tech than healthcare to MM. However, it’s in the healthcare sector and does again demonstrate the recent weakness in the space, having retreated over 12% from its July high.

Read more

12/08/2025 09:04

Pro Medicus Ltd (PME) $304.77

PME is an Australian healthcare technology company that develops and supplies medical imaging software and services to hospitals, diagnostic imaging groups, and healthcare providers worldwide - it's more of a tech than a healthcare stock.

Read more

10/04/2025 09:37

Pro Medicus Ltd (PME) $188.14

We have discussed health imaging technology company PME several times in recent months, delivering the same message: it's an exciting growth stock but too expensive.

Read more